Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients

Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients

Item
http://www.wikidata.org/entity/Q28267079
Factors affecting treatment adherence to atomoxetine in ADHD: a systematic reviewPharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy.Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo-Controlled, Randomized Trials.Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention-Deficit/Hyperactivity Disorder.A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.Cross-species studies of cognition relevant to drug discovery: a translational approach.Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults With ADHD: Relationship to Maintenance of Response and Relapse Over the Subsequent 6 Months After Treatment.Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects.A Signature of Attention-Elicited Electrocortical Activity Distinguishes Response From Non-Response to the Non-Stimulant Atomoxetine in Children and Adolescents With ADHD.Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan.Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial.
P2860

Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients

Item
http://www.wikidata.org/entity/Q28267079
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Atomoxetine in patients with A ...... and implications for patients
@ast
Atomoxetine in patients with A ...... and implications for patients
@en
Atomoxetine in patients with A ...... and implications for patients
@nl
type
label
Atomoxetine in patients with A ...... and implications for patients
@ast
Atomoxetine in patients with A ...... and implications for patients
@en
Atomoxetine in patients with A ...... and implications for patients
@nl
prefLabel
Atomoxetine in patients with A ...... and implications for patients
@ast
Atomoxetine in patients with A ...... and implications for patients
@en
Atomoxetine in patients with A ...... and implications for patients
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P577
P698
P921
P3181
P356
P1433
P1476
Atomoxetine in patients with A ...... and implications for patients
@en
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P577
P698
P921